Neuroblastoma Clinical Trials in Hartford, Connecticut
9 recruitingHartford, Connecticut
Showing 1–9 of 9 trials
Recruiting
Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
NeuroblastomaGanglioneuroblastoma, Nodular
National Cancer Institute (NCI)478 enrolled177 locationsNCT06172296
Recruiting
Phase 2
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Giselle Sholler98 enrolled12 locationsNCT06540963
Recruiting
Phase 2
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Giselle Sholler500 enrolled28 locationsNCT02559778
Recruiting
Phase 1Phase 2
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
OsteosarcomaEwing SarcomaNeuroblastoma+4 more
Milton S. Hershey Medical Center289 enrolled10 locationsNCT06465199
Recruiting
Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
NeuroblastomaGanglioneuroblastoma, NodularGanglioneuroblastoma
Children's Oncology Group750 enrolled162 locationsNCT03126916
Recruiting
Not Applicable
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Neuroblastoma
Dana-Farber Cancer Institute84 enrolled6 locationsNCT06831552
Recruiting
Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Giselle Sholler131 enrolled31 locationsNCT04301843
Recruiting
Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Giselle Sholler93 enrolled23 locationsNCT05489887
Recruiting
Phase 2
Neuroblastoma Maintenance Therapy Trial
Neuroblastoma
Giselle Sholler441 enrolled49 locationsNCT02679144